跳至主要内容
临床试验/ITMCTR2100004537
ITMCTR2100004537招募中1 期

Effect of Qishen Huoxue Granules on coagulopathy/early DIC in sepsis and its mechanism

Beijing Friendship Hospital, Capital Medical University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 -(—)
性别
All

入选标准

  • Adults >= 18 years old, meet SEPSIS 3.0 diagnostic criteria and have coagulopathy/early DIC. 1) Sepsis inclusion criteria, according to SEPSIS 3.0 diagnostic criteria. 2) Coagulation disorders/early DIC, refer to the International Society of Thrombosis and Hemostasis DIC scoring system (ISTH) for diagnosis. DIC scores of 3 to 4 are included.

排除标准

  • 1) Pregnant or breastfeeding women;
  • 2) Aged < 18 years;
  • 3) Platelets < 30,000/L;
  • 4) Patient has life-threatening active bleeding;
  • 5) 12 hours before and after major surgery on chest, abdomen, skull, peripheral blood vessels and other parts Internal;
  • 6) a history of severe brain injury and intracranial surgery;
  • 7) intracranial vascular malformations, cerebral hemangioma, large central central lesions and stroke within three months;
  • 8) hemophilia and other congenital coagulation diseases;
  • 9) The patients previous severe liver cirrhosis, esophageal varices or bleeding history and current ascites;
  • 10) Severe gastrointestinal, respiratory, urinary tract bleeding, gastrointestinal leakage; a history of gastrointestinal, urinary tract bleeding within 6 weeks Hemorrhage in the tract or respiratory tract requires special treatment;
  • 11) have used aspirin > 650 mg/d or warfarin in the past 7 days, or have undergone thrombolytic therapy in the past 1 month;
  • 12) the patient is dying (estimated Died within 6 hours);
  • 13) Known or suspected brain death;
  • 14) Is undergoing dialysis treatment;
  • 15) The patient is undergoing other treatment studies that may interfere with this study.

研究者

相似试验